Mycestericins A, B, C, D and E were isolated from the culture broth of Mycelia sterilia ATCC 20349 along with thermozymocidin (=myriocin). Their structures were elucidated on the basis of spectroscopic studies and chemical evidence. The acetate of mycestericin C was identical with the acetate of 6,7-dihydromyriocin. Mycestericins suppressed the proliferation of lymphocytesin the mouseallogeneic mixed lymphocytereaction, with a potency similar to that of myriocin.
We have very recently reported2)3) that a metabolite of Isaria Sinclairii (ATCC 24400) showed potent immunosuppressiveactivity. Its activities in the mouseallogeneic mixed lymphocyteand mouseallogeneic cytotoxic T lymphocyte assays were 10 times and 100 times those of cyclosporin A (CsA), respectively. The metabolite was identical with myriocin4'5) (1, Fig. 1 ) and thermozymocidin6), which are produced by Myriococcum albomyces (ATCC16425) and Mycelia sterilia (ATCC20349), respectively. Reduction of the ketone at C-14 of 1 to a methylene increased the activity 10-fold7). Therefore, it seemed possible that Each mycelium (wet weight 1 g) was extracted with MeOH(5ml) and the extracts [the extract of (1) injection, 10 fi\; column, YMC-packed column AQ-3 12
(6 x 150mm). 421 even moreactive immunosuppressantsthan 1 might be found in the culture broth of myriocin-producing microorganisms, such as the fungi, /. sinclairii, M. sterilia and M. albomyces. The MeOHextracts from mycelia of these three fungi showed immunosuppressive activity, and several minor compounds along with 1 as the major components were detected by HPLC analyses (Fig. 2) . In order to investigate the minor components we selected M. sterilia, because this strain produced the greatest amount of 1 and the minor components, mycestericins, amongthe above three strains. The present paper describes the isolation, the structural determination and the biological activities of mycestericins isolated from the culture broth of M. sterilia.
Results and Discussion

Isolation of Mycestericins
Mycestericins were isolated from the culture broth of Mycelia sterilia as shown in Fig. 3 . The MeOHextract was subjected to Amberlite XAD-2column chromatography to give Frs. 1 and 2. Preparative HPLCof Fr. 1 gave mycestericins A (2) and B (3), while Fr. 2 gave mycestericins D (5) and E (6) along with crude 1 containing mycestericin C (4). Structural Determination Mycestericin A (2) Mycestericin A (2) was obtained as a white powder and its physico-chemical properties are summarized in Table 1 . Based on the MSdata, the molecular formula was determined as C2iH39NO6.The IR spectrum was similar to that of 1 except for the absence of the 1710cm"1 absorption (C=O). The XHNMRspectra of 2 and its acetate were also similar to those of 1 and its acetate, respectively (Tables 2 and 4 ). These facts suggested the presence of partial structure I (Fig. 4 ) in 2. The methylene proton signals at 3 2.43 (13-H2 and 15-H2) and 1.53 (12-H2 and 16-H2) of 1 were absent in the spectrum of 2. On the other hand, the signals oftrans olefinic protons [<5 5.59 (1H, dtd, /= 15.3, 6.8 and 0.8 Hz) and 5.40 (1H, ddt-like, /= 15.3 and 6.8Hz)] and a methine proton on carbon bearing oxygen 1 (3 3.95 (1H, brq, .7=6.8 Hz) ] appeared in the XHNMR spectrum of 2. In the 1H-1HCOSYspectrum of 2 cross peaks were observed for the signals suggesting formation of y-lactone followed by cleavage at C-14 to give an allylic alcohol ion (III, Fig. 4) . Thus, the plane structure of mycestericin A was established as (£,^)-2-amino-3,4, 14-trihydroxy-2-hydroxymethyleicosa-6,12-dienoic acid (2) . The structure was supported by the 13C NMRspectrum of 2 and its acetate (Tables 3 and 4) .
In order to determine the absolute configuration at C-2 to C-4 and at C-14 of 2, the benzoate CD chirality method was employed. Tribenzoyl-14-deoxytetrahydromycestericin A y-lactone was synthesized by benzoylation of 2 followed by hydrogenolysis. The spectra (IR and XHNMR)and optical rotation were identical with those of an authentic sample (12, Fig. 6 ) derived from 1. Furthermore, the CDspectra were virtually superimposable (Fig. 7) . Consequently, the absolute configurations at C-2 to C-4 were determined to be IS 3R and 4R, as in 1. On the other hand, 7V-acetyl-14-0-benzoylmycestericin A y-lactone (10) was synthesized by benzoylation of JV-acetylmycestericin A (8) followed by partial hydrolysis. The CD spectrum showeda negative Cotton effect at 236 nm( Fig. 8) , suggesting that the absolute configuration of the hydroxy group at C-14 is R8'9). Thus, the structure of mycestericin A was determined to be 2, as shown in Fig properties are summarized in Table 1 . The *H NMRspectrum of 3 was similar to that of 1 (Table 2) . However, the methylene proton signals at 3 2.43 (13-H2 and 15-H2) and 3 1.53 (12-H2 and 16-H2) in 1 were not observed in the spectrum of 3. Instead, the signals of a methine proton on a carbon bearing oxygen (3 3.50, 1H) was observed in the spectrum of 3. These facts indicated the presence of a hydroxy group at C-14 in 3. The spectral data of 3 were identical with those of (£)-2-amino-3,4,14-trihydroxy-2-hydroxymethyleicos-6-enoic acid7) (la). The CD curve of tetrabenzoyldihydromycestericin B y-lactone (16) showed good coincidence with those of tetrabenzoyltetrahydromycestericin A y-lactone (13) and a tetrabenzoate (14) derived from tetrahydromyriocin (Fig. 9) . Thus, the absolute configurations at C-2 to C-4 of 3 are 2S, 3R and 4R, respectively. Consequently, the structure of mycestericin B corresponds to 3. However, the absolute configuration of the carbon bearing hydroxyl group at C-14 was not elucidated.
Mycestericin C (4) HPLCanalysis showed that crude 1 contained a minor component (4) , whose Rf value on TLCwas almost the same as that of 1. The retention time of 4 identical with that of 6,7-dihydromyriocin7). However, it was difficult to isolate in a pure form by preparative HPLC.Therefore, the acetyl derivative of crude 1 was treated with OsO4 and the non-reactive compound (mycestericin C triacetate) was purified by preparative TLC. The spectra (*H NMR,IR and MS) and [a] D value were identical with those of triacetyl-6,7-dihydromyriocin y-lactone (Table 5) . Consequently, mycestericin C (4) was determined to be
Mycestericin D (5) Mycestericin D (5) was obtained as a white powder and its physico-chemical properties are summarized in Table 1 . Based on the MSdata, the molecular formula was determined as C21H39NO5, suggesting that 5 is the deoxy derivative ofmyriocin (1). The *H NMRspectrum of5 was similar to that of 1, except for the signals of a methine proton on carbon bearing oxygen (3 3.83, 4-H) and allylic methylene protons (3 2.26, 5-H2) in 1 (Fig. 10) .
In the^^H COSYspectrum of5, cross peaks were observed for the signals at 3 3.84 (3-H) . These observations indicated the presence of a methylene group at C-4. Accordingly, the plane structure of mycestericin D was concluded to be 5.
Mycestericin E (6)
Mycestericin E (6), C21H39NO5,was obtained as a white powder and its physico-chemical properties are summarized in Table 1 . Although the XHNMRspectrum of 6 was very similar to that of 5, signals ofmethylene protons (3 1.53, 2H) at C-4 of5 appeared at 3 1.70 and 3 1.41 in the spectrum of6. Thê^H COSYspectrum of 6 showed cross peaks for the signals at 3 1.70 (4-H)/3 2.27 (5-H) and 3 2.05 12 derived from 1 (c 0.518 x 10~3m), 12 derived from 2 (c 0.559 x 10"3m).
Fie. 8. CD spectrum of10 (c 2.18x 10"3m).
A mixture of 14-jR and S. Absolute configuration at C-14 is not determined. APR. 1994 (5-H); 3 1.41 (4-H)/<5 2.27 (5-H), 3 2.05 (5-H) and 3 3.85 (3-H) . Accordingly, the plane structure of mycestericin D (6) was concluded to be the same as that of 5 and the two compoundsare in a diastereoisomeric relationship.
Effect of Mycestericins on Mouse Allogeneic Mixed Lymphocyte Reaction (MLR)
The effect of mycestericins A (2), B (3), D (5) and E (6) on mouse allogeneic MLRwas examined in Fig. 9 . CD spectra of13, 14 and 16.
13 (c 0.458x10"3m), 14 (c 0.475x 10'3m), 16 (c 0.422x 10~3m).
comparison with that of 1. Table 6 shows the IC50 values of mycestericins and 1 on mouseallogeneic MLR.The potency of 2, 3 and 5 was comparable to that of 1, while 6 showed somewhat weaker activity. It appears that the hydroxy group at C-4
has not effect on the activity.
E xperimen t al General Methods
Melting points were determined on a Yanagimoto micro melting point apparatus without correction. Optical rotations were measured with a Jasco DIP-181 digital polarimeter. UV and IR spectra were taken on a Shimadzu UV-2200 UV-VIS recording spectrophotometer and a Shimadzu IR-435 infrared spectrophotometer, respectively. CDspectra were measured on a Jasco J-720 spectrophotometer. The and preparative TLC were performed on Kieselgel 60F254 (Merck) and Kieselgel 60PF254 (Merck), respectively. Organic extracts of reaction mixtures were washed successively with 1 n HC1, 5% NaHCO3 and saturated aqueous NaCland dried over anhydrous magnesiumsulfate unless otherwise specified.
Fermentation of Mycelia sterilia (ATCC20349)
A seed medium (100ml) containing glucose 3%, yeast extract (Difco) 0.5%, K2HPO40.03% and MgSO4-7H2O0.05% at pH 5.5 was poured into a 500-ml Erlenmeyer flask and sterilized at 121°C for 20minutes. Mycelium growing on the potato-dextrose agar (Difco) was inoculated into the medium and cultured at 40°C for 4days on a reciprocal shaker (145 strokes/minute). The resultant culture was transferred to the same medium (5 liters) in a 10-liter jar fermentor which had been sterilized at 121°C for 30minutes in advance. The seed fermenter was operated for 4days at 40°C, with agitation at 150rpm and with an air flow of 5liters per minute.
For production, a 200-liter fermentor was used. The medium (150liters) was composed of glucose 3%, L-glutamic acid monosodium salt 0.5%, K2HPO4 0.1%, MgSO4-7H2O 0.2%, citric acid 0.05%, FS anti foam F-18 (DowCorning Co., Ltd.) and 10ml per liter of a trace element solution containing
FeSO4-7H2O 0.1%, MnCl2 -4H2O 0.1%, ZnSO4-7H2O 0.1%, thiamine hydrochloride 0.02%, pantothenic acid sodium salt 0.02% and riboflavin 0.02%. The production fermentor was inoculated with 4.5 liters of broth from the seed fermentor and operated for 10 days at 40°C, with an air flow rate of 150 liters/minute, a pressure of 0.8kg/cm2 and an agitator speed of 150rpm.
Isolation and Purification Mycestericins were isolated from the culture broth of Mycelia sterilia (ATCC 20349) as shown in Fig. 3 . The culture broth (150liters) was separated into filtrate and mycelium by filtration. The mycelium (6.2 kg) was extracted with MeOH(25 liters x 2). The MeOHextract was diluted with water (50 liters), and the mixture was passed through a column of Amberlite XAD-2(18.4 liters). The column was washed with 50% (20liters) and 60% aqueous MeOH(30liters), then eluted with 70% (15 liters, Fr. 1, 0.45 g) and 80% aqueous MeOH(20liters, Fr. 2, 4.3g) . A portion of Fr. 2 was concentrated to dryness and the residue was recrystallized from MeOHto give crude 1 containing 4. On the other hand, most of Fr. 2 was rechromatographed on Amberlite XAD-2 (3 liters) with 80% aqueous MeOHto give Fr. 3 (0.31 g).
Fr. 1 was subjected to semi-preparative HPLCto give 2 (150mg; retention time, 63minutes) and 3 (40mg; retention time, 91~92minutes). Similar treatment of Fr. 3 gave 5 (39mg; retention time,
92~93 minutes) and 6 (33 mg; retention time, 100~102minutes).
Mouse Allogeneic Mixed Lymphocyte Reaction (MLR)
The effect of mycestericins on mouseallogeneic MLRwas examined by the method described in our previous paper2).
Tetraacetylmycestericin A y-Lactone (7) Acetic anhydride (1.0ml) was added to a solution of 2 (20.0mg) in pyridine (1.0ml). The mixture was kept standing overnight, then poured into ice water and extracted with CHC13.The organic solution was washed, dried and concentrated to give an oily residue, which was purified by preparative TLC[solvent, Table 4 ).
JV-Acetylmycestericin A y-Lactone (8) Acetic anhydride (3.4ml) was added to a suspension of 2 (80.0mg) in absolute MeOH(1.3ml) and the mixture was refluxed for 10 hours. The solvent was evaporated off and CHC13was added to the residue. The organic solution was washed and concentrated to give an oily residue. The residue was purified by preparative TLC [solvent, 1H, 7=15.3 and6.3Hz, 4.59 (1H, brs, 4.57 (1H, brt, 7=6.3Hz, 4.01 (1H, 7=6.3Hz, 3.85 (2H, brs, 2.55 (2H, brt, 7=6.3Hz, 2.ll (3H, s, m, m, m, 1.27 (8H, brs, 0.88 (3H, t, 7=6.2Hz, . 13C NMR (50MHz, CDC13) <5: 174.53 and 173.80 (each s, 1-C and >C=O), 134.81 and 132.91 (each d, 131.96 (d, 123.64 (d, 83.22 (d, 73.29 and 72.34 (each d, 67.53 (s, 63.63 (t, 37.31 (t, 32.18 (t, 31.87 and 31.79 (each t, 29.19 and 25.44 (each t, 28.34 and 28.24 (each t, 22.99 (q, 22.60 (t, 14.08 (q, . EI-MS m/z 425 (M+), 377, 340, 322, 292, 141, 67, 43. HREI-MS calcd for C23H39NO6: 425.2779 , found: 425.2786 7V-Acetyltribenzoylmycestericin A y-Lactone (9) Benzoic anhydride (105.8 mg) was added to a solution of 8 (20.0 mg) and iV,iV-dimethylaminopyridine (ll.4mg) in Et3N (1.0ml) and the mixture was kept standing overnight. Ice water was added and the mixture was extracted with CHC13.The organic solution was washed and concentrated to give an oily residue. The residue was purified by preparative TLC [solvent, ] to give 9 as an oil (28.3mg, 81.6%). IRvmax (CHCl^cm"1: 3400, 1780 , 1725 , 1685 (sh), 1600 iV-Acetyl-14-O-benzoylmycestericin A y-Lactone (10) A solution of9 (20.0mg) in MeOH (1.5 ml) containing 1 n NaOH (0.17ml) was stirred for 90minutes, adjusted to pH 2 with 1 n HC1, and further stirring was continued for another 45 hours. The mixture was neutralized with 1 n NaOHand extracted with CHC13. The organic solution was washed and concentrated to give an oily residue. The residue was purified by preparative TLC [solvent, Tetrabenzoylmycestericin A y-Lactone (ll)
By a procedure similar to that used for the preparation of 9, ll (35.7mg) was obtained as an oil in 68% yield from 2 (26.5mg).
[a]D +28.6°(c 0.313, EtOH). CDAext (EtOH)nm: 239 (As 10.6), 224 (-2.2). IRvmax (CHCycnr1: 2920 , 1730 , 1675 , 1600, 970, 710. *H NMR (270MHz, CDC13) S: 8. m, 6.82 (1H, s, NH), 6.23 (1H, d, /=4.6Hz, 5.75 (1H, dt, J=14.2 and 6.9Hz, m, 4.95 (overlap, 1H, dt, and 4.6Hz, 4.93 (overlap, 2H, s, m, m, Tribenzoyl-1 4-deoxodihydromyriocin y-Lactone (12) By a procedure similar to that used for the preparation of9, 12 (28.2 mg) was obtained as an amorphous powder in 83% yield from 14-deoxo-6,7-dihydromyriocin7).
[a]D + 54.2°(c 0.81, EtOH). CDAext (EtOH) Tribenzoyl-1 4-deoxytetrahydromycestericin A y-Lactone (12) and Tetrabenzoyltetrahydromycestericin A y-Lactone (13) A solution of ll (34.5mg) in MeOH(30ml) was hydrogenated over 5% Pd/C (3mg) in the presence of HC1O4.The catalyst was filtered off and the filtrate was evaporated. The residue was purified by Acetic anhydride (l ml) was added to a solution of crude myriocin (lOOmg) in pyridine (l ml) and the reaction mixture was stirred at room temperature overnight, then poured into ice water and extracted with EtOAc. The organic solution was washed and concentrated to give an oily residue (1 15 mg). Asolution of the residue (100mg) in pyridine (5ml) was treated with a solution of OsO4 (57mg) in pyridine (1 ml). VOL.47 NO.4 THE JOURNAL OF ANTIBIOTICS 433 The mixture was stirred for 2hours, then 1%aqueous NaHSO3(5 ml) was added. The whole was diluted with water, and extracted with EtOAc. The organic solution was washed and concentrated to afford a residue. The residue was purified by preparative TLC [solvent, ] to give 6mg of 17 as an oil (see Table 5 ).
